Hypertonic Saline + Furosemide for Heart Failure

(DESAL-HEART Trial)

FG
JE
Overseen ByJustin Ezekowitz, MD
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: University of Alberta
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

DESAL-HEART is a multicenter, randomized, open-label, blinded-endpoint, mechanistic proof-of-concept trial conducted within the Heart Failure Efficacy and Research Trial (HEART) Platform. The study will evaluate whether adding a single infusion of 3% hypertonic saline solution (HSS) to a pre-declared intravenous furosemide dose improves decongestion in patients hospitalized with acute heart failure.

Are You a Good Fit for This Trial?

This trial is for adults hospitalized with acute heart failure who need intravenous diuretics. People with certain other serious health problems or conditions that could interfere with the study may not be able to join.

Inclusion Criteria

Serum sodium ≥125 mmol/L and <145 mmol/L
NT-proBNP ≥1000 pg/mL regardless of atrial fibrillation presence
Estimated glomerular filtration rate (eGFR) >15 mL/min/1.73 m²
See 5 more

Exclusion Criteria

Treating physician's judgment that treatment strategy is inappropriate or any condition making participation unsafe or interfering with study results interpretation
I have already received hypertonic saline during this hospital visit.
Requirement for mechanical circulatory support
See 3 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests if adding a single dose of hypertonic saline (a salty solution) to standard IV furosemide (a water pill given by vein) helps remove extra fluid better in people with sudden heart failure. Participants are randomly assigned to treatment groups.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Hypertonic Saline Plus FurosemideExperimental Treatment2 Interventions
Group II: Furosemide AloneActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+

Canadian VIGOUR Centre

Collaborator

Trials
9
Recruited
11,000+

University Hospital Foundation

Collaborator

Trials
8
Recruited
1,800+